BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1216 related articles for article (PubMed ID: 23712469)

  • 21. Use of T1-weighted/T2-weighted magnetic resonance ratio to elucidate changes due to amyloid β accumulation in cognitively normal subjects.
    Yasuno F; Kazui H; Morita N; Kajimoto K; Ihara M; Taguchi A; Yamamoto A; Matsuoka K; Takahashi M; Nakagawara J; Iida H; Kishimoto T; Nagatsuka K
    Neuroimage Clin; 2017; 13():209-214. PubMed ID: 28003959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging.
    Zhao Y; Raichle ME; Wen J; Benzinger TL; Fagan AM; Hassenstab J; Vlassenko AG; Luo J; Cairns NJ; Christensen JJ; Morris JC; Yablonskiy DA
    Neuroimage; 2017 Mar; 148():296-304. PubMed ID: 27989773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subthreshold Amyloid Predicts Tau Deposition in Aging.
    Leal SL; Lockhart SN; Maass A; Bell RK; Jagust WJ
    J Neurosci; 2018 May; 38(19):4482-4489. PubMed ID: 29686045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amyloid-β load predicts medial temporal lobe dysfunction in Alzheimer dementia.
    Frings L; Spehl TS; Weber WA; Hüll M; Meyer PT
    J Nucl Med; 2013 Nov; 54(11):1909-14. PubMed ID: 24101684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional Tau Deposition Reflects Different Pathways of Subsequent Neurodegeneration and Memory Decline in Cognitively Normal Older Adults.
    Chen X; Toueg TN; Harrison TM; Baker SL; Jagust WJ
    Ann Neurol; 2024 Feb; 95(2):249-259. PubMed ID: 37789559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting Alzheimer disease with β-amyloid imaging: results from the Australian imaging, biomarkers, and lifestyle study of ageing.
    Rowe CC; Bourgeat P; Ellis KA; Brown B; Lim YY; Mulligan R; Jones G; Maruff P; Woodward M; Price R; Robins P; Tochon-Danguy H; O'Keefe G; Pike KE; Yates P; Szoeke C; Salvado O; Macaulay SL; O'Meara T; Head R; Cobiac L; Savage G; Martins R; Masters CL; Ames D; Villemagne VL
    Ann Neurol; 2013 Dec; 74(6):905-13. PubMed ID: 24448836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B.
    Leinonen V; Alafuzoff I; Aalto S; Suotunen T; Savolainen S; Någren K; Tapiola T; Pirttilä T; Rinne J; Jääskeläinen JE; Soininen H; Rinne JO
    Arch Neurol; 2008 Oct; 65(10):1304-9. PubMed ID: 18695050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amyloid-β associated cortical thinning in clinically normal elderly.
    Becker JA; Hedden T; Carmasin J; Maye J; Rentz DM; Putcha D; Fischl B; Greve DN; Marshall GA; Salloway S; Marks D; Buckner RL; Sperling RA; Johnson KA
    Ann Neurol; 2011 Jun; 69(6):1032-42. PubMed ID: 21437929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging.
    Chen MK; Mecca AP; Naganawa M; Finnema SJ; Toyonaga T; Lin SF; Najafzadeh S; Ropchan J; Lu Y; McDonald JW; Michalak HR; Nabulsi NB; Arnsten AFT; Huang Y; Carson RE; van Dyck CH
    JAMA Neurol; 2018 Oct; 75(10):1215-1224. PubMed ID: 30014145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.
    Schreiber S; Schreiber F; Lockhart SN; Horng A; Bejanin A; Landau SM; Jagust WJ;
    JAMA Neurol; 2017 Jun; 74(6):650-659. PubMed ID: 28319241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Verbal episodic memory impairment in Alzheimer's disease: a combined structural and functional MRI study.
    Rémy F; Mirrashed F; Campbell B; Richter W
    Neuroimage; 2005 Mar; 25(1):253-66. PubMed ID: 15734360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longitudinal patterns of β-amyloid deposition in nondemented older adults.
    Sojkova J; Zhou Y; An Y; Kraut MA; Ferrucci L; Wong DF; Resnick SM
    Arch Neurol; 2011 May; 68(5):644-9. PubMed ID: 21555640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Covarying alterations in Aβ deposition, glucose metabolism, and gray matter volume in cognitively normal elderly.
    Oh H; Habeck C; Madison C; Jagust W
    Hum Brain Mapp; 2014 Jan; 35(1):297-308. PubMed ID: 22965806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of gray matter atrophy with age, β-amyloid, and cognition in aging.
    Oh H; Madison C; Villeneuve S; Markley C; Jagust WJ
    Cereb Cortex; 2014 Jun; 24(6):1609-18. PubMed ID: 23389995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hippocampal and cortical atrophy in amyloid-negative mild cognitive impairments: comparison with amyloid-positive mild cognitive impairment.
    Ye BS; Seo SW; Kim CH; Jeon S; Kim GH; Noh Y; Cho H; Yoon CW; Kim HJ; Jang EY; Lee J; Kim JH; Chin J; Lee JM; Kim JH; Seong JK; Kim CH; Choe YS; Lee KH; Na DL
    Neurobiol Aging; 2014 Feb; 35(2):291-300. PubMed ID: 24080178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relevance of magnetic resonance imaging for early detection and diagnosis of Alzheimer disease.
    Teipel SJ; Grothe M; Lista S; Toschi N; Garaci FG; Hampel H
    Med Clin North Am; 2013 May; 97(3):399-424. PubMed ID: 23642578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amyloid imaging in Alzheimer's disease and other dementias.
    Fodero-Tavoletti MT; Cappai R; McLean CA; Pike KE; Adlard PA; Cowie T; Connor AR; Masters CL; Rowe CC; Villemagne VL
    Brain Imaging Behav; 2009 Sep; 3(3):246-61. PubMed ID: 22005989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inferior temporal tau is associated with accelerated prospective cortical thinning in clinically normal older adults.
    Scott MR; Hampton OL; Buckley RF; Chhatwal JP; Hanseeuw BJ; Jacobs HI; Properzi MJ; Sanchez JS; Johnson KA; Sperling RA; Schultz AP
    Neuroimage; 2020 Oct; 220():116991. PubMed ID: 32512123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spatial Patterns of Longitudinal Gray Matter Change as Predictors of Concurrent Cognitive Decline in Amyloid Positive Healthy Subjects.
    Araque Caballero MÁ; Klöppel S; Dichgans M; Ewers M;
    J Alzheimers Dis; 2017; 55(1):343-358. PubMed ID: 27662291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amyloid Beta-Weighted Cortical Thickness: A New Imaging Biomarker in Alzheimer's Disease.
    Kim CM; Hwang J; Lee JM; Roh JH; Lee JH; Koh JY;
    Curr Alzheimer Res; 2015; 12(6):563-71. PubMed ID: 26027813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 61.